Prostate Cancer Treatment Shifts Observed From 2004 to 2023
Researchers analyzed claims data for nearly 30,000 men to reveal changing clinical approaches to localized prostate cancer.
Updated on Sept. 23, 2026 in Men’s Health
Live Poll
Do you believe medical guidelines effectively encourage doctors to prioritize less invasive cancer treatments?
A retrospective study of 29,484 men under 65 showed that active surveillance rates for localized prostate cancer rose to 35.1% between 2004 and 2023. Meanwhile, the use of surgery, specifically prostatectomy, declined during the same period to 42.8%.
Why it matters
These shifting patterns suggest a broader acceptance of active surveillance as a viable management strategy for localized cancer, potentially driven by more rigorous implementation of clinical guidelines.
The study tracked a median patient age of 58.0 years with a 68.8% five-year treatment-free survival rate for those on active surveillance. MRI usage among these patients reached 63.7%, while PSA testing reached 97.0% within the first two years.
The details
Researchers reviewed the Merative Marketscan Commercial Database to evaluate how clinical management of localized prostate cancer has evolved. The team utilized descriptive statistics and Kaplan-Meier analyses to confirm that surveillance is increasingly preferred over invasive procedures.
Timeline
The study analyzed prostate cancer claims data spanning from 2004 to 2023.
Health Landscape
This research follows a pattern set by the implementation of the NCCN clinical practice guidelines for prostate cancer. These standards have increasingly prioritized active surveillance to avoid the side effects associated with unnecessary surgical interventions.
Patients may experience fewer side effects from invasive surgeries as active surveillance becomes a more standard primary management option. Men diagnosed with localized cancer should discuss with their physicians whether their specific case qualifies for a surveillance-first approach.
The takeaway
The move toward active surveillance highlights a precision medicine approach that prioritizes quality of life for younger patients. Men should work closely with their urologists to evaluate if monitoring is a safer alternative to immediate surgery based on their specific diagnostic profile.
Further reading
For more information on current treatment standards, visit the Men’s Health section.
More information
Access the research findings on the journal urology website.
Source note: This article includes information reported by InsuranceNewsNet.
Live Poll
Do you believe medical guidelines effectively encourage doctors to prioritize less invasive cancer treatments?
